Rapid Micro Biosystems Files 8-K

Ticker: RPID · Form: 8-K · Filed: Jan 16, 2025 · CIK: 1380106

Rapid Micro Biosystems, Inc. 8-K Filing Summary
FieldDetail
CompanyRapid Micro Biosystems, Inc. (RPID)
Form Type8-K
Filed DateJan 16, 2025
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: 8-K, filing, disclosure

Related Tickers: RMBS

TL;DR

RMBS filed an 8-K, mostly standard disclosures. No major news.

AI Summary

On January 16, 2025, Rapid Micro Biosystems, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with a Regulation FD disclosure. No specific financial figures or material events were detailed in the provided excerpt.

Why It Matters

This filing indicates ongoing reporting requirements for Rapid Micro Biosystems, Inc. to the SEC, which is standard for publicly traded companies.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report and does not appear to contain any new material information that would immediately impact the company's risk profile.

Key Players & Entities

  • RAPID MICRO BIOSYSTEMS, INC. (company) — Registrant
  • 001-40592 (company) — SEC File Number
  • 20250116 (date) — Report Date
  • January 16, 2025 (date) — Report Date
  • 25 Hartwell Avenue, Lexington, MA 02421 (company) — Business Address

FAQ

What is the primary purpose of this 8-K filing for Rapid Micro Biosystems, Inc.?

The filing is primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits.

What is the exact date of the earliest event reported in this filing?

The date of the earliest event reported is January 16, 2025.

What is the company's principal executive office address?

The principal executive offices are located at 25 Hartwell Avenue, Lexington, MA 02421.

What is the SEC file number for Rapid Micro Biosystems, Inc.?

The SEC file number is 001-40592.

What is the standard industrial classification for Rapid Micro Biosystems, Inc.?

The SIC code is 3826, for Laboratory Analytical Instruments.

Filing Stats: 508 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2025-01-16 08:33:39

Key Financial Figures

  • $0.01 — which registered Class A Common Stock, $0.01 par value per share RPID The Nasdaq Cap

Filing Documents

01

Item 7.01 Regulation FD Disclosure. On January 16, 2025, Rapid Micro Biosystems, Inc. updated its corporate presentation for use in meetings with investors, analysts and others. The presentation is available through the Investor Relations section of its website and a copy of the presentation is furnished as Exhibit 99.1 to this report. The information furnished under this Item 7.01, including Exhibit 99.1 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as otherwise expressly stated in such filing.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Corporate Presentation 104 Cover Page Interactive Data File (formatted as inline XBRL)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. RAPID MICRO BIOSYSTEMS, INC. Date: January 16, 2025 By: /s/ Sean Wirtjes Sean Wirtjes Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.